BioNexus Gene Lab Corp. (BGLC) Free cash flow 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.9MFY2025 · since FY2018: -$313,701 → -$1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.9M | +19.2% |
| FY2024 | -$2.3M | -17.7% |
| FY2023 | -$2.0M | -457.3% |
| FY2022 | $551,822 | +9098.6% |
| FY2021 | $5,999 | -95.4% |
| FY2020 | $131,059 | +157.0% |
| FY2019 | -$230,090 | +26.7% |
| FY2018 | -$313,701 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice